Stock ORGO ORGANOGENESIS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Real-time Estimate Cboe BZX
Other stock markets
 18:40:12 21/05/2024 BST 		5-day change 1st Jan Change
2.815 USD +1.62% Intraday chart for Organogenesis Holdings Inc. -1.20% -31.27%
05-13 Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating MT
05-10 Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup DJ

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN
AQ
Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating
MT
Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup
DJ
Organogenesis: Q1 Earnings Snapshot
AQ
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M
MT
Transcript : Organogenesis Holdings Inc., Q1 2024 Earnings Call, May 09, 2024
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
AQ
Organogenesis Holdings Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024
CI
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
AQ
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
CI
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
AQ
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
AQ
Transcript : Organogenesis Holdings Inc., Q4 2023 Earnings Call, Feb 29, 2024
Organogenesis: Q4 Earnings Snapshot
AQ
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q4 Revenue $99.7M, vs. Street Est of $109.1M
MT
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
AQ
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024
CI
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORGO Stock
  4. News Organogenesis Holdings Inc.